Lumosa Therapeutics (6535.TWO) Earnings Analysis
Lumosa Therapeutics (6535.TWO) has no confirmed upcoming earnings date. Last quarter (2026-05-11) it beat with EPS -0.72 TWD vs -0.72 TWD est (0%). It has beaten estimates in 3/6 recent quarters (50%). Trailing P/E -41.26.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 6535.TWO next report earnings?
No confirmed upcoming earnings date is currently scheduled for 6535.TWO. This page updates as the calendar is published.
6535.TWO earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-05-11 | -0.72 TWD | -0.72 TWD | 0% | Beat |
| 2026-02-23 | -0.34 TWD | -0.51 TWD | +33.3% | Beat |
| 2025-11-12 | -0.2 TWD | -0.5 TWD | +60% | Beat |
| 2025-08-08 | -0.89 TWD | -0.54 TWD | -64.8% | Miss |
| 2025-05-05 | -0.63 TWD | -0.48 TWD | -31.3% | Miss |
| 2024-12-31 | -0.90137 TWD | n/a | n/a | n/a |
| 2024-11-11 | -1.4 TWD | -0.51 TWD | -174.5% | Miss |
Beat rate: 3/6 (50%) over reported quarters with consensus data.
6535.TWO valuation and analyst view
| Trailing P/E | -41.26 |
|---|---|
| Trailing EPS | -2.14183 TWD |
| Price / book | 10.57 |
| Dividend yield | 0.00% |
| Market cap | 14.97B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is Lumosa Therapeutics (6535.TWO)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 6535.TWO. This page updates as the calendar is published.
Did 6535.TWO beat earnings last quarter?
In its 2026-05-11 report, 6535.TWO posted EPS of -0.72 TWD versus a -0.72 TWD estimate — a beat of 0%.
What is 6535.TWO's earnings track record?
Over the last 6 reported quarters with consensus data, 6535.TWO beat estimates 3 times (50%).
What is 6535.TWO's current P/E ratio and EPS?
6535.TWO trades at a trailing P/E of -41.26 on trailing EPS of -2.141831897588912 TWD.
What do analysts rate 6535.TWO?
6535.TWO has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.